India Still Viable for Drug Innovation, Hisey Says

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Sales Check With Hudson's Bay CEO Jerry Storch
07:49 - Hudson's Bay CEO Jerry Storch weighs in on Black Friday sales. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Black Friday Retail Sales: The Winners & the Losers
  • Battle of the Charts: Retail Traffic, Euro Versus Dollar
  • 2016 Will Be a Better Year for Stocks, Here's Why